These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8912717

  • 1. Dispase-mediated basal detachment of cultured keratinocytes induces urokinase-type plasminogen activator (uPA) and its receptor (uPA-R, CD87).
    Schaefer BM, Reinartz J, Bechtel MJ, Inndorf S, Lang E, Kramer MD.
    Exp Cell Res; 1996 Nov 01; 228(2):246-53. PubMed ID: 8912717
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The plasminogen-activating system in hepatic stellate cells.
    Leyland H, Gentry J, Arthur MJ, Benyon RC.
    Hepatology; 1996 Nov 01; 24(5):1172-8. PubMed ID: 8903394
    [Abstract] [Full Text] [Related]

  • 7. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
    Niedbala MJ, Bajetta S, Carbone R, Sartorelli AC.
    Cancer Commun; 1990 Nov 01; 2(9):317-24. PubMed ID: 2169831
    [Abstract] [Full Text] [Related]

  • 8. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T, Behrendt N, Ploug M.
    Stem Cells; 1997 Nov 01; 15(6):398-408. PubMed ID: 9402652
    [Abstract] [Full Text] [Related]

  • 9. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A, Soeltl R, Lutz V, Wilhelm OG, Magdolen V, Rojo EE, Hantzopoulos PA, Graeff H, Gänsbacher B, Schmitt M.
    Cancer Gene Ther; 2000 Feb 01; 7(2):292-9. PubMed ID: 10770639
    [Abstract] [Full Text] [Related]

  • 10. Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells.
    Ragno P, Montuori N, Covelli B, Hoyer-Hansen G, Rossi G.
    Cancer Res; 1998 Mar 15; 58(6):1315-9. PubMed ID: 9515821
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis.
    Schaefer BM, Jaeger C, Drepper E, Kramer MD.
    Autoimmunity; 1996 Mar 15; 23(3):155-64. PubMed ID: 8879451
    [Abstract] [Full Text] [Related]

  • 12. Urokinase expression and binding activity associated with the transforming growth factor beta1-induced migratory and invasive phenotype of mouse epidermal keratinocytes.
    Santibáñez JF, Frontelo P, Iglesias M, Martínez J, Quintanilla M.
    J Cell Biochem; 1999 Jul 01; 74(1):61-73. PubMed ID: 10381262
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
    Wohn KD, Kanse SM, Deutsch V, Schmidt T, Eldor A, Preissner KT.
    Thromb Haemost; 1997 Mar 01; 77(3):540-7. PubMed ID: 9066008
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical and molecular characterization of cultured keratinocytes after dispase-mediated detachment from the growth substratum.
    Schaefer BM, Wallich R, Schmolke K, Fink W, Bechtel M, Reinartz J, Kramer MD.
    Exp Dermatol; 2000 Feb 01; 9(1):58-64. PubMed ID: 10688376
    [Abstract] [Full Text] [Related]

  • 16. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
    Teesalu T, Blasi F, Talarico D.
    Dev Dyn; 1998 Sep 01; 213(1):27-38. PubMed ID: 9733098
    [Abstract] [Full Text] [Related]

  • 17. Expression of the helix-loop-helix protein ID1 in keratinocytes is upregulated by loss of cell-matrix contact.
    Schaefer BM, Koch J, Wirzbach A, Kramer MD.
    Exp Cell Res; 2001 Jun 10; 266(2):250-9. PubMed ID: 11399053
    [Abstract] [Full Text] [Related]

  • 18. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
    Quemener C, Gabison EE, Naïmi B, Lescaille G, Bougatef F, Podgorniak MP, Labarchède G, Lebbé C, Calvo F, Menashi S, Mourah S.
    Cancer Res; 2007 Jan 01; 67(1):9-15. PubMed ID: 17210677
    [Abstract] [Full Text] [Related]

  • 19. Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.
    Reinartz J, Schaefer B, Bechtel MJ, Kramer MD.
    Exp Cell Res; 1996 Feb 25; 223(1):91-101. PubMed ID: 8635500
    [Abstract] [Full Text] [Related]

  • 20. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
    Reuning U, Magdolen V, Hapke S, Schmitt M.
    Biol Chem; 2003 Aug 25; 384(8):1119-31. PubMed ID: 12974381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.